Focuses on biomaterials-enabled immunotherapies and vaccines: polymer platforms for transdermal and oral delivery, polymer–adjuvant design, and microbiome modulation. Builds rapid separations and translational allergy/autoimmunity models to evaluate antigen-specific tolerance and de‑risk development.